This physician-guided approach uses FDA-approved therapy to promote sustainable weight reduction. GLP-1 receptor agonists mimic a natural hormone in the body, helping regulate appetite, slow digestion, and support healthy blood sugar levels. A medical evaluation is required before starting, and every plan is tailored to the individual’s history and goals.

GLP-1 therapy activates receptors that help regulate hunger and fullness signals in the brain and digestive system. These effects may help reduce appetite, slow gastric emptying, and encourage more balanced blood sugar responses. Semaglutide weight loss protocols, for example, have been studied in clinical settings and may support gradual, meaningful weight reduction when paired with lifestyle guidance. Individual results vary.

Adults who have had difficulty managing their body composition through diet and exercise alone, and who have a BMI or health profile appropriate for medical care, may be candidates. A thorough consultation is required to review your background, current medications, and goals before any program begins. GLP-1 therapies are not appropriate for everyone.

Semaglutide and tirzepatide are both prescription medications used in medically supervised programs. Semaglutide activates GLP-1 receptors to help regulate appetite and digestion, while tirzepatide for weight loss works by targeting both GLP-1 and GIP receptors, making it a dual-action option. Both require a prescription and ongoing clinical oversight. Your provider will determine which approach, if any, is appropriate after a full evaluation.

Most patients may begin noticing changes within the first several weeks, though meaningful, sustained outcomes typically develop over multiple months when combined with behavioral adjustments. Progress varies by individual and depends on health history, dosage, and adherence to the plan. Gradual, consistent improvement is the goal.

Pricing varies based on the care plan, therapy selected, and frequency of visits. We encourage you to schedule a consultation at our San Diego or Vista location so we can provide transparent, accurate cost details tailored to your specific situation. Our team will walk you through every available option during your appointment.

Duration is highly individual. Some patients remain on a plan for several months, while others continue with ongoing medical supervision for longer periods. Your provider will monitor your progress regularly and adjust your protocol based on outcomes, tolerance, and long-term wellness goals.

Common side effects may include nausea, digestive discomfort, and appetite changes, particularly in the early weeks of treatment. More serious side effects are possible and will be reviewed during your clinical consultation. All options used at Botoxie are FDA-approved, and your provider will carefully review your background to help minimize risk.

Yes. A medical evaluation, which may include lab work, is required before beginning any GLP-1 program. Ongoing clinical oversight is central to the process, including regular provider check-ins and progress monitoring. This structure ensures your safety and allows your care team to make timely adjustments as needed.

Body weight changes after discontinuing a GLP-1 medication are possible and vary by individual. That is why the program strongly emphasizes building lasting habits alongside this treatment. Long-term success depends on maintaining the nutritional routines, physical activity, and healthy patterns developed throughout your care.